drugset / Trial / NCT01251003

Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury

NCT01251003

Phase 1/2 Withdrawn Charles Cox
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if it is safe to use stored autologous Human Umbilical Cord Blood (hUCB) to treat pediatric patients that sustain a severe or moderate Traumatic Brain Injury (TBI), and have not fully recovered as measured by the Glasgow Outcome Score-Expanded (GOS-EC)/Child at 6 to 18 months post-injury.

Timeline

Start
2011-01
Primary completion
2014-12
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous cord blood Cell therapy 1e+10 cells/kg Intravenous